Product Name | (R)-2-(3-(4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carbonyl)-4-methyl-4-(4-(oxetan-3-yl)piperazin-1-yl)pent-2-enenitrile |
Synonyms | PRN1008;Rilzabrutinib;5G1WE425BI;(R,E)-2-(3-(4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carbonyl)-4-methyl-4-(4-(oxetan-3-yl)piperazin-1-yl)pent-2-enenitrile;Rilzabrutinib [INN];Rilzabrutinib [USAN];Rilzabrutinib, (E)-;Rilzabrutinib (USAN/INN);GTPL9993;BDBM143212;(E)-2-[(3R)-3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4- |
Catalog No. | H-050744 |
CAS No. | 1575591-66-0 |
Molecular Formula | C36H40FN9O3 |
Molecular Weight | 665.7597 |
Smile Code | CC(N1CCN(C2COC2)CC1)(C)C=C(C(N3C[C@H](N4N=C(C5=CC=C(OC6=CC=CC=C6)C=C5F)C7=C(N)N=CN=C74)CCC3)=O)C#N |
InChI | |
EINECS | |
Density | |
Melting point | |
Boiling point | |
Refractive index | |
Water solubility | |
Hazard Symbols | |
Risk Codes | |
Safety Description |